Loading capability details…
Ginwu1
Skill detail
Internal QA listing to verify the Stripe Accounts v2 destination-charge payment flow end to end. Not a real capability.
Publisher declaration. Caporia observations and recorded checks are identified separately below.
Seller of record: CAPORIA LLC. This is a Caporia first-party package.
Publisher profile: Ginwu1. This identifies the listing profile, not a separate seller.
Package owner/licensor: CAPORIA LLC. The package license defines permitted use.
Purchase support and refunds: CAPORIA LLC — support@caporia.co and refunds@caporia.co.
Other listings on Caporia may be sold by approved publishers; each purchase page states its seller.
Caporia assessment — scope and limits
The publisher approved this deterministic Trust Summary from the current capability materials and reviewed Evidence.
Price
$79
Category
Automation
Version
0.1.0
Trust Summary
Approved
Fit information — publisher declarations
Review this published capability against your use case before adoption.
Helps buyers address this use case: Internal QA listing, not for real use.
Time to first value
Depends on repository size and the selected workflow.
Buyer profile
Caporia's internal QA and engineering team, verifying the Stripe Connect Accounts v2 destination-charge payment flow before it is exposed to real publishers and buyers.
Runtime fit
None. This listing has no runtime component and is never executed.
Publisher-declared compatibility
These environments are declared by the publisher. A Caporia test supports compatibility only when its separate record names the environment and result.
Trust Center
Trust Summary for Test Capability - Accounts v2 QA — Internal QA listing to verify the Stripe Accounts v2 destination-charge payment flow end to end. Not a real capability. 0 reviewed Evidence items, 0 accepted reviews, 0 reviewed validation runs, and 3 documentation items were available to summarize.
Evidence
Caporia observations — see source and scope
Decision reason
Trust Summary
Marketplace signal
Active licenses
Not publicly reported
Evidence
4 items
Observations
3 items
Validation evidence
See scoped review record